Key Takeaways: Shares of XCHG nearly tripled in their first week of trading after the company raised $20.7 million in its Nasdaq IPO The company’s revenue jumped 52% and its profit nearly quadrupled in this year’s first quarter, but it warned of a slowdown in the second quarter By Edith Terry
A trio of biotech companies' shares rose on Friday in their first trading sessions. Bicara Therapeutics, MBX Biosciences, and Zenas BioPharma each sold more shares in their respective initial public offerings than they had planned.
